Characterization of HIV diversity, phylodynamics and drug resistance in Washington, DC.
Washington DC has a high burden of HIV with a 2.0% HIV prevalence. The city is a national and international hub potentially containing a broad diversity of HIV variants; yet few sequences from DC are available on GenBank to assess the evolutionary history of HIV in the US capital. Towards this gener...
Main Authors: | Marcos Pérez-Losada, Amanda D Castel, Brittany Lewis, Michael Kharfen, Charles P Cartwright, Bruce Huang, Taylor Maxwell, Alan E Greenberg, Keith A Crandall, DC Cohort Executive Committee |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5621693?pdf=render |
Similar Items
-
Prevalence and trends in transmitted and acquired antiretroviral drug resistance, Washington, DC, 1999–2014
by: Annette M. Aldous, et al.
Published: (2017-09-01) -
Site assessment survey to assess the impact of the COVID-19 pandemic on HIV clinic site services and strategies for mitigation in Washington, DC
by: Nicole Barish, et al.
Published: (2023-10-01) -
Validation of publicly-available software used in analyzing NGS data for HIV-1 drug resistance mutations and transmission networks in a Washington, DC, Cohort.
by: Kamwing Jair, et al.
Published: (2019-01-01) -
Use of national standards to monitor HIV care and treatment in a high prevalence city-Washington, DC.
by: Amanda D Castel, et al.
Published: (2017-01-01) -
Psychosocial impacts of the COVID-19 pandemic from a cross-sectional Survey of people living with HIV in Washington, DC
by: Anne K. Monroe, et al.
Published: (2023-05-01)